<DOC>
	<DOC>NCT01643811</DOC>
	<brief_summary>The purpose of this study is to determine whether the extent of gastrectomy and anastomosis type affect chronic metabolic disease such as diabetes and hypertension in early gastric cancer patients.</brief_summary>
	<brief_title>Effect of Gastrectomy and Anastomosis on Diabetes and Hypertension in Early Gastric Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Histologically proven primary gastric adenocarcinoma clinical stage Ia or Ib examined with endoscopy, endoscopic ultrasound, and computed tomography aged 2080 year old, performance status (PS) of 0 or 1 on Eastern Cooperative Oncology Group (ECOG) scale diagnosed as diabetes or hypertension patients planning to undergo gastrectomy or endoscopic submucosal dissection written informed consent having high risk for operation such as severe heart disease, severe respiratory disease pregnant previous abdominal surgery or radiation therapy proven more advanced disease than pathological stage II requiring adjuvant chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>early gastric cancer, diabetes, hypertension</keyword>
</DOC>